Bumrungrad Hospital
Bumrungrad Hospital (SET: BH) is Thailand's premier medical-tourism operator β the first hospital in Asia to earn JCI accreditation (2002) and the listed Thai operator with the highest international-patient revenue mix (>60% FY2024). FY2024 revenue in the THB 25B range on single-asset operations (Bumrungrad Hospital Sukhumvit). Patient origin mix is diversified across GCC, ASEAN, Western markets, and Chinese/Japanese segments. The strategy is international, premium-domestic cash-pay; Bumrungrad does not compete aggressively in UCS or SSS contracts.
Snapshot
Headline numbers a buyer checks first.
FY2024 revenue
~THB 25B
FY2024
International-patient share
>60%
FY2024
Highest in listed Thai hospital stack
JCI accreditation
First in Asia (2002)
Since 2002
Hospital footprint
Single flagship (Sukhumvit)
FY2024
Listing
SET: BH
1991
What this company actually does
Bumrungrad operates as a single-asset medical-tourism flagship from its Sukhumvit Soi 3 hospital. The facility serves 1.1+ million patient visits annually, including over 520,000 international patients from more than 190 countries. Specialty strengths cluster around cardiology (Bumrungrad Heart Centre), orthopaedics, oncology (Horizon Cancer Centre), cosmetic surgery, dermatology, and fertility (Bumrungrad IVF Centre). The hospital's operating philosophy combines JCI-aligned clinical quality with hospitality-grade patient experience β which is the core of Thailand's medical-tourism value proposition.[]
The single-asset concentration is both the strength and the risk. Operationally it lets Bumrungrad maintain tight quality control, concentrated physician recruitment, retention, and uniform patient-experience standards. Strategically it leaves BH exposed to any disruption of the Bangkok medical-tourism corridor (GCC diplomatic friction, COVID-style border closure, reputational event) with no geographic diversification to fall back on. For investors, BH is the purest listed medical-tourism play but the single-asset concentration requires acceptance.[]
Clinical specialties and patient origin mix
Cardiology
Bumrungrad Heart Centre is the flagship cardiac specialty, attracting GCC and South Asian patients seeking non-surgical and surgical cardiac care.
Oncology
Horizon Cancer Centre handles radiotherapy, chemotherapy, and surgical oncology. Growing segment as cancer-screening awareness rises in medical-tourism origin markets.
Orthopaedics and fertility
Joint replacement, sports medicine, and Bumrungrad IVF Centre serve both expatriate-resident and medical-tourist populations.
GCC patient corridor
Middle East (Saudi, UAE, Kuwait, Oman) accounts for an estimated 25-30% of international-patient revenue. Political or diplomatic friction carries direct revenue risk.
ASEAN and South Asian corridor
Myanmar, Cambodia, Bangladesh, Pakistan β price-sensitive markets; Bumrungrad competes on quality vs cost vs closer-to-home alternatives.
Western, Japanese segment
Expatriate Bangkok residents, Japanese health-check tourism, European cosmetic-procedure seekers complete the diversity.
Thailand top listed hospital groups β scale and international mix
Revenue, hospital count, and international-patient intensity for the major listed Thai private-hospital operators.
| Group | Ticker | FY2024 revenue | Hospitals | International-patient share |
|---|---|---|---|---|
| BDMS | SET:BDMS | > $3.19B | 50+ | ~30% system-wide |
| Bumrungrad Hospital | SET:BH | ~ $724.6M | 1 | >60% |
| Bangkok Chain Hospital | SET:BCH | ~ $492.8M | 20+ | <10% |
| Thonburi Healthcare | SET:THG | ~ $347.8M | 10+ | ~15% |
Watchpoints for the next annual report
International-patient mix stability
Any shift below 55% would signal corridor disruption or domestic-revenue dilution.
GCC corridor trajectory
Middle-East patient flow is the largest single origin bucket; political-risk-sensitive.
Physician compensation, retention
Single-site workforce concentration makes retention economics critical.
Second-hospital expansion?
Periodic discussion of second flagship (Phuket, Chiang Mai) β would materially change the concentration thesis.
Related Market profiles
Peers, parents, partners, agencies, and other Hospitals & Medical Tourism actors.
Competitor
Bangkok Dusit Medical Services
Largest scale; Bangkok Hospital brand competes in medical tourism.
Open Market profile β
Competitor
Thonburi Healthcare Group
Diversified wellness-plus-hospital peer.
Open Market profile β
Sector peer
Asian Cosmetic Surgery Center
Bangkok cosmetic surgery center serving domestic and international patients.
Open Market profile β
Sector peer
Bangkok Chain Hospital
Mid-market listed hospital operator β Kasemrad brand across 15+ hospitals; SSS, UCS contract-heavy franchise.
Open Market profile β
Sources + data provenance
Every filing, filing-adjacent register, or trusted industry source cited in this profile.
Bumrungrad Hospital (SET: BH) FY2024 Form 56-1 One Report
| Source | Publisher | Grade | As of |
|---|---|---|---|
| Bumrungrad Hospital (SET: BH) FY2024 Form 56-1 One Report | Bumrungrad Hospital PCL | Primary | 2025-03-15 |
Reports featuring this profile
Thailand Premium AR/VR Headset Apple Vision Meta Quest 2027 Market Intelligence
Bumrungrad International surgical VR planning programme with Magic Leap 2 and Vision Pro for complex case rehearsal in cardiology, neurosurgery, and oncology; private-hospital flagship.
Open report β
Sits alongside 2 other Atlas profilesThailand Hair Transplant FUE & Aesthetic Medical Tourism 2027 Market Intelligence
Bumrungrad aesthetic division with hair-loss treatment, skin and body procedures; large international patient base
Open report β
Sits alongside 3 other Atlas profilesThailand Senior Living & Foreign-Retiree Villages 2027 Market Intelligence
SET-listed Bumrungrad premium continuing-care programme targeting European and Gulf cohorts at THB 55,000 to 110,000 monthly tiers
Open report β
Sits alongside 2 other Atlas profilesThailand Anti-Aging & Longevity Clinics 2027 Market Intelligence
Bumrungrad's flagship integrated longevity wing; Executive Longevity Assessment USD 12,000 to 18,000 per 3 to 5 day visit; Hong Kong, Singapore and Middle East inbound anchor; expanding stem-cell and
Open report β
Sits alongside 1 other Atlas profileThailand Precision Medicine & Genomics 2027 Market Intelligence
Horizon Center delivers whole-exome sequencing, pharmacogenomics, CDx for international patients; THB 120-180K package range; Middle East, Cambodia, Indonesia channel.
Open report β
Sits alongside 4 other Atlas profilesThailand Senior Long-Stay & Retirement Visa 2027 Market Intelligence
International-patient leader; Vitallife Wellness; long-stay package and NCD focus
Open report β
Sits alongside 6 other Atlas profilesThailand Hospital REIT & Asset-Light Healthcare 2027 Market Intelligence
Single-flagship Sukhumvit campus, 1.1M annual patients, primary medical-tourism property unlock candidate
Open report β
Sits alongside 4 other Atlas profilesThailand Dental Tourism & Premium Implants 2027 Market Intelligence
Listed high-end medical tourism dental segment
Open report β
Sits alongside 1 other Atlas profileThailand Mental Health & Wellness Tech 2027 Market Intelligence
Largest international-tier private psychiatry, medical-tourism inbound
Open report β
Thailand Indian Inbound Tourism & Business Corridor 2027
JCI-accredited Bangkok tertiary hospital; Hindi-language services, South-Asia patient coordinators.
Open report β
Sits alongside 7 other Atlas profilesThailand Silver Economy & Aging Society 2027 Market Intelligence
Medical-tourism flagship; senior wellness, Bumrungrad Home Care
Open report β
Sits alongside 6 other Atlas profilesThailand Medical Tourism 2027: The Corridor Thesis
Medical-tourism flagship, JCI since 2002 (first in Asia), 170+ Arabic-language support staff
Open report β
Sits alongside 4 other Atlas profilesThailand LGBT Marriage Equality Economy Market Intelligence
Tertiary medical-tourism hub; Pride Clinic, HRT, affirming primary care; high-income inbound.
Open report β
Sits alongside 7 other Atlas profilesThailand Cosmetic Surgery & Aesthetic Medicine Market Intelligence
Premium JCI hospital with Esperance Aesthetic Clinic and Vitallife wellness; high-net-worth international patient base.
Open report β
Sits alongside 5 other Atlas profilesThailand Wellness and Spa Industry Market Intelligence
SET: BH hospital-anchored medical wellness; Bang Krachao retreat
Open report β
Sits alongside 9 other Atlas profilesThai Digital Health: Telemedicine, Doctor Raksa, and Hospital Adoption
International-patient-anchored hospital; digital integrations, EMR.
Open report β
Sits alongside 5 other Atlas profilesThe Thai Private Hospital Tier Map: BDMS Empire, Bumrungrad Premium, and Bangkok Hospital Network
Premium-international-patient-anchored; USD 1B+ revenue.
Open report β
Sits alongside 4 other Atlas profilesCosmetic Surgery and Aesthetic Tourism: The Korean-Adjacent Bangkok Cluster
Premium-tier cosmetic-and-aesthetic procedures within international-patient hospital.
Open report β
Sits alongside 5 other Atlas profilesThai Private Healthcare Cost Advantage: Why a Bypass in Bangkok Costs USD 15K Not USD 75K
JCI-accredited 2002 first Asia; Sukhumvit Soi 3 flagship.
Open report β
Sits alongside 5 other Atlas profilesBangkok Medical Tourism: BDMS, Bumrungrad, and the USD 4-6B Private-Hospital Health-Travel Tier
JCI-accredited 2002 first in Asia; Sukhumvit Soi 3 flagship.
Open report β
Sits alongside 3 other Atlas profilesBangkok Dusit Medical Services (BDMS): Private Hospital Network Economics
Single-site premium tertiary in central Bangkok (SET: BH); ~580 beds; international patient revenue >60% β Middle East accounts for 25-30% of BH revenue; the benchmark for international-intensity in T
Open report β
Sits alongside 2 other Atlas profilesBCH Bangkok Chain Hospital: Mid-Market Positioning and IPO Aftermath
Single-site 580-bed tertiary in Bangkok (SET: BH); 1.1M patients per year from 190 countries; first Asian JCI accreditation 2002; international patients 66% of revenue in 1H 2023; premium-internationa
Open report β
Sits alongside 2 other Atlas profilesThai Aging Population: Pension Reform and the Private-Healthcare Demand Curve
Premium international hospital; aging-population and medical-tourism cohort intersection.
Open report β
Sits alongside 7 other Atlas profilesThai Medical Tourism: Acuity Mix and the International-Cohort Recovery
International-cohort flagship
Open report β
Sits alongside 2 other Atlas profilesThailand Healthcare Services & Medical Tourism Market Intelligence
Medical-tourism flagship; first JCI in Asia; >60% international-patient revenue.
Open report β
Sits alongside 7 other Atlas profilesThailand Wellness & Spa Market Intelligence
Bumrungrad International operates wellness, anti-aging clinic adjacent to hospital.
Open report β
Sits alongside 5 other Atlas profilesThailand Medical Cannabis & CBD Market Intelligence
Bumrungrad operates licensed medical-cannabis prescription clinic.
Open report β
Sits alongside 4 other Atlas profilesThailand Digital Health & Telemedicine Market Intelligence
Bumrungrad International telemedicine, digital-health platform.
Open report β
Sits alongside 4 other Atlas profilesThailand Elder Care & Assisted Living Market Intelligence
Bumrungrad senior, rehabilitation programmes.
Open report β
Sits alongside 2 other Atlas profilesThailand Medical Tourism Pricing & Economics Deep Dive
Bumrungrad International Hospital β iconic Thai medical tourism flagship.
Open report β
Sits alongside 7 other Atlas profilesThailand Hospital Group Consolidation Deep Dive
Bumrungrad International flagship; listed separately as SET: BH.
Open report β
Sits alongside 7 other Atlas profilesThailand Diagnostic Lab & Imaging Deep Dive
Medical tourism flagship, N Health reference lab parent.
Open report β
Sits alongside 6 other Atlas profilesThailand Thai Massage & Spa Wellness Deep Dive
Bumrungrad VitalLife medical wellness, longevity.
Open report β
Sits alongside 6 other Atlas profilesThailand Medical Tourism Arrivals & Origin Mix Deep Dive
Medical-tourism flagship; ~1.1M+ international encounters annually.
Open report β
Sits alongside 6 other Atlas profilesThailand Diabetes, Insulin, Chronic Disease Pharma Deep Dive
Diabetes specialist clinic, insulin, GLP-1 dispensing.
Open report β
Sits alongside 2 other Atlas profilesThailand Cold-Chain Pharma, Vaccine Deep Dive
Bumrungrad downstream cold-chain pharma demand.
Open report β
Sits alongside 6 other Atlas profilesThailand Funeral Services & End-of-Life Deep Dive
Bumrungrad medical-tourism, foreign retiree death, repatriation.
Open report β
Sits alongside 5 other Atlas profilesThailand Life Sciences, Biotech, GPO BioPharm Deep Dive
Premier clinical-trial site, medical-tourism Phase I-IV trials
Open report β
Sits alongside 3 other Atlas profilesRelated Market profiles
competitor
Bangkok Dusit Medical Services
Thailand's largest listed hospital group β 50+ hospitals across six brand families; >THB 110B FY2024 revenue.
competitor
Thonburi Healthcare Group
Diversified healthcare, wellness, senior-living group β pivot toward aging-population services and medical-hub property.